CDC approves COVID vaccines for kids as young as 6 months
Centers for Disease Control and Prevention Director Dr. Rochelle Walensky endorsed on Saturday an advisory committee's recommendation that the Pfizer and Moderna COVID-19 vaccines be approved for children aged six months to five years, CBS News reported.
CDC approval was the final step in getting shots into toddlers' arms after the Food and Drug Administration authorized COVID vaccines for kids on Friday.
The CDC said in a statement that "all Americans ages 6 months and older are now eligible for vaccination" and that "[a]ll children, including children who have already had COVID-19, should get vaccinated."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Moderna vaccine will be given to young children in the form of two quarter-strength injections one month apart, while the Pfizer-BioNTech vaccine will be administered in three doses — each one-tenth the strength of those given to adults — over 11 weeks.
Most parents don't seem particularly eager to get their tots vaccinated. A poll by the Kaiser Family Foundation found that only 18 percent of parents with children under five planned to vaccinate their kids as soon as possible.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Grayson Quay was the weekend editor at TheWeek.com. His writing has also been published in National Review, the Pittsburgh Post-Gazette, Modern Age, The American Conservative, The Spectator World, and other outlets. Grayson earned his M.A. from Georgetown University in 2019.
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published